HEADER VIRAL PROTEIN 14-APR-25 9QWI TITLE THE N-TERMINAL DOMAIN (44-180) OF THE SARS-COV-2 NUCLEOCAPSID TITLE 2 PHOSPHOPROTEIN USING AN AUTOMATIC ASSIGNMENT/MODELING SOFTWARE COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEOPROTEIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: N,NUCLEOCAPSID PROTEIN,NC,PROTEIN N; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_TAXID: 2697049; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS MULTIDOMAIN PROTEIN, AUTOMATIC ASSIGNMENT/MODELING, VIRAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR M.SCHIAVINA,T.BOLOGNESI,I.C.FELLI,R.PIERATTELLI REVDAT 2 17-SEP-25 9QWI 1 JRNL REVDAT 1 13-AUG-25 9QWI 0 JRNL AUTH T.BOLOGNESI,M.SCHIAVINA,I.C.FELLI,R.PIERATTELLI JRNL TITL NMR INSIGHTS ON MULTIDOMAIN PROTEINS: THE CASE OF THE JRNL TITL 2 SARS-COV-2 NUCLEOPROTEIN. JRNL REF PROG NUCL MAGN RESON V.-149 01577 2025 JRNL REF 2 SPECTROSC JRNL REFN ISSN 1873-3301 JRNL PMID 40912879 JRNL DOI 10.1016/J.PNMRS.2025.101577 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.SCHIAVINA,L.PONTORIERO,V.N.UVERSKY,I.C.FELLI,R.PIERATTELLI REMARK 1 TITL THE HIGHLY FLEXIBLE DISORDERED REGIONS OF THE SARS-COV-2 REMARK 1 TITL 2 NUCLEOCAPSID N PROTEIN WITHIN THE 1-248 RESIDUE CONSTRUCT: REMARK 1 TITL 3 SEQUENCE-SPECIFIC RESONANCE ASSIGNMENTS THROUGH NMR. REMARK 1 REF BIOMOL NMR ASSIGN V. 15 219 2021 REMARK 1 REFN ESSN 1874-270X REMARK 1 PMID 33660218 REMARK 1 DOI 10.1016/J.BBAPAP.2010.01.011 REMARK 1 REFERENCE 2 REMARK 1 AUTH M.SCHIAVINA,L.PONTORIERO,G.TAGLIAFERRO,R.PIERATTELLI, REMARK 1 AUTH 2 I.C.FELLI REMARK 1 TITL THE ROLE OF DISORDERED REGIONS IN ORCHESTRATING THE REMARK 1 TITL 2 PROPERTIES OF MULTIDOMAIN PROTEINS: THE SARS-COV-2 REMARK 1 TITL 3 NUCLEOCAPSID PROTEIN AND ITS INTERACTION WITH ENOXAPARIN. REMARK 1 REF BIOMOLECULES V. 12 2022 REMARK 1 REFN ESSN 2218-273X REMARK 1 PMID 36139141 REMARK 1 DOI 10.3390/BIOM10111541 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ARTINA REMARK 3 AUTHORS : KLUKOWSKI, P., RIEK, R. AND GUNTERT, P. REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9QWI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-APR-25. REMARK 100 THE DEPOSITION ID IS D_1292146583. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 170 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 450 UM [U-100% 13C; U-100% 15N] REMARK 210 NTD (44-180) OF N PROTEIN FROM REMARK 210 SARS-COV-2, 0.03 % NAN3, 150 MM REMARK 210 KCL, 95 % H2O, 5 % [U-2H] D2O, REMARK 210 95% H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 13C CACO; 2D REMARK 210 13C CBCACO; 2D 13C CON; 3D HNCO; REMARK 210 3D 13C (H)CBCACON REMARK 210 SPECTROMETER FIELD STRENGTH : 950 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : ARTINA, XEASY REMARK 210 METHOD USED : DISTANCE GEOMETRY REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 46 -173.43 -69.83 REMARK 500 1 ASN A 47 47.71 -95.22 REMARK 500 1 THR A 54 179.74 -59.31 REMARK 500 1 LEU A 64 121.94 67.69 REMARK 500 1 ASN A 77 44.25 -93.16 REMARK 500 1 LYS A 127 119.25 -176.29 REMARK 500 1 LYS A 143 58.52 -103.25 REMARK 500 1 SER A 176 170.87 -53.94 REMARK 500 2 PRO A 46 -179.07 -69.80 REMARK 500 2 ASN A 47 48.97 -90.78 REMARK 500 2 LEU A 64 124.85 67.81 REMARK 500 2 ASN A 77 41.91 -93.25 REMARK 500 2 LEU A 104 171.06 -55.72 REMARK 500 2 LYS A 127 121.32 -176.74 REMARK 500 2 ALA A 134 137.22 -176.65 REMARK 500 2 LYS A 143 58.70 -105.12 REMARK 500 3 ASN A 47 109.83 -53.06 REMARK 500 3 ASN A 48 59.70 -98.17 REMARK 500 3 LEU A 64 125.58 68.13 REMARK 500 3 ASN A 77 45.85 -91.36 REMARK 500 3 LYS A 127 120.63 -176.25 REMARK 500 3 ALA A 134 137.08 -172.01 REMARK 500 3 LYS A 143 58.79 -105.21 REMARK 500 3 VAL A 158 108.32 -50.56 REMARK 500 4 PRO A 46 -174.24 -69.74 REMARK 500 4 THR A 54 -173.35 -59.41 REMARK 500 4 LEU A 64 122.66 67.53 REMARK 500 4 ASN A 77 44.89 -93.11 REMARK 500 4 LYS A 127 121.13 -176.56 REMARK 500 4 LYS A 143 58.28 -105.02 REMARK 500 5 LEU A 45 137.38 66.31 REMARK 500 5 PRO A 46 -173.28 -69.79 REMARK 500 5 THR A 54 170.22 -51.92 REMARK 500 5 LEU A 64 122.17 67.04 REMARK 500 5 ASN A 77 44.75 -90.73 REMARK 500 5 GLU A 118 59.45 -90.15 REMARK 500 5 LYS A 127 122.50 -176.68 REMARK 500 5 LYS A 143 59.80 -105.19 REMARK 500 6 ASN A 48 58.01 -98.63 REMARK 500 6 THR A 54 177.33 -56.27 REMARK 500 6 LEU A 64 118.92 67.58 REMARK 500 6 ASN A 77 49.84 -88.60 REMARK 500 6 GLU A 118 57.82 -93.35 REMARK 500 6 LYS A 127 125.03 -172.93 REMARK 500 6 ALA A 134 140.95 -171.75 REMARK 500 6 LYS A 143 58.22 -105.58 REMARK 500 6 SER A 176 104.61 -52.31 REMARK 500 7 THR A 54 -179.68 -56.78 REMARK 500 7 LEU A 64 127.78 67.89 REMARK 500 7 ASN A 77 40.82 -93.40 REMARK 500 REMARK 500 THIS ENTRY HAS 148 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 51620 RELATED DB: BMRB DBREF 9QWI A 44 180 UNP P0DTC9 NCAP_SARS2 44 180 SEQRES 1 A 137 GLY LEU PRO ASN ASN THR ALA SER TRP PHE THR ALA LEU SEQRES 2 A 137 THR GLN HIS GLY LYS GLU ASP LEU LYS PHE PRO ARG GLY SEQRES 3 A 137 GLN GLY VAL PRO ILE ASN THR ASN SER SER PRO ASP ASP SEQRES 4 A 137 GLN ILE GLY TYR TYR ARG ARG ALA THR ARG ARG ILE ARG SEQRES 5 A 137 GLY GLY ASP GLY LYS MET LYS ASP LEU SER PRO ARG TRP SEQRES 6 A 137 TYR PHE TYR TYR LEU GLY THR GLY PRO GLU ALA GLY LEU SEQRES 7 A 137 PRO TYR GLY ALA ASN LYS ASP GLY ILE ILE TRP VAL ALA SEQRES 8 A 137 THR GLU GLY ALA LEU ASN THR PRO LYS ASP HIS ILE GLY SEQRES 9 A 137 THR ARG ASN PRO ALA ASN ASN ALA ALA ILE VAL LEU GLN SEQRES 10 A 137 LEU PRO GLN GLY THR THR LEU PRO LYS GLY PHE TYR ALA SEQRES 11 A 137 GLU GLY SER ARG GLY GLY SER HELIX 1 AA1 SER A 79 ASP A 82 5 4 SHEET 1 AA1 2 LEU A 56 GLN A 58 0 SHEET 2 AA1 2 PHE A 171 ALA A 173 -1 O TYR A 172 N THR A 57 SHEET 1 AA2 3 ARG A 107 TYR A 112 0 SHEET 2 AA2 3 ILE A 84 ALA A 90 -1 N ARG A 88 O TYR A 109 SHEET 3 AA2 3 ILE A 130 ALA A 134 -1 O VAL A 133 N GLY A 85 SHEET 1 AA3 2 ARG A 93 ARG A 95 0 SHEET 2 AA3 2 MET A 101 ASP A 103 -1 O LYS A 102 N ILE A 94 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1 ENDMDL MODEL 2 ENDMDL MODEL 3 ENDMDL MODEL 4 ENDMDL MODEL 5 ENDMDL MODEL 6 ENDMDL MODEL 7 ENDMDL MODEL 8 ENDMDL MODEL 9 ENDMDL MODEL 10 ENDMDL MODEL 11 ENDMDL MODEL 12 ENDMDL MODEL 13 ENDMDL MODEL 14 ENDMDL MODEL 15 ENDMDL MODEL 16 ENDMDL MODEL 17 ENDMDL MODEL 18 ENDMDL MODEL 19 ENDMDL MODEL 20 ENDMDL MASTER 163 0 0 1 7 0 0 6 1051 1 0 11 END